undamentalytics Newsletter

Howell Peyton R: insider trades

Officer, Director at 2 companies we cover. 2 open-market purchases and 17 sales not made under a pre-set plan, reported from June 22, 2012 to May 19, 2023.

Would copying Howell Peyton R’s purchases have beaten the S&P 500?

Too few purchases to judge. Only 2 purchases have 12 months of prices after the report; we judge insiders once they have 20. The figures below can swing a long way on a handful of trades. Buying each purchase the day after it was reported, an equal amount each, and holding it 12 months or until they reported a sale would have turned $10,000 on May 11, 2022 into $8,914 by November 2, 2026, −2.5% a year. The copy held shares only 45% of the time, so the fair comparison is the S&P 500 on those same days with Treasury bills otherwise: $15,220, +9.9% a year (the S&P 500 held throughout made $20,458, +17.4% a year). Beta against the index was 0.75. Twelve months after each report, the average purchase was −7.1% against the S&P 500 (median −7.1%), and 50% beat it. Measured from the trade date, the insider’s own timing, the average was −16.2%. After their sales, the shares moved −3.9% against the index over 12 months on average (a negative figure means selling was the right call); 77% trailed it.

With 296 insiders tested, some will look skilled or unskilled by chance alone: when we replaced each insider’s stocks with random companies bought on the same days, about 5.7 cleared the bar ahead and 23.3 behind. One record on its own proves little.

$0$10.0k$20.0k 20222023202420252026 $20.5k$15.2k$8.9k
Copying Howell Peyton RS&P 500, same days investedS&P 500, held throughout $10,000 copying Howell Peyton R’s open-market purchases from May 11, 2022, before costs and taxes, marked weekly. Each purchase gets the same starting stake, bought at the close of the first trading day after the report and sold 12 months later or the day after a reported sale of that stock; uninvested money earns the Treasury bill rate. “Same days invested” holds the S&P 500 only on the days the copy held shares, Treasury bills otherwise.
Return a year, copying
−2.5%
S&P 500, same days invested
+9.9% (held throughout +17.4%)
Time in shares
45%
Sharpe ratio (S&P 500)
0.08 (0.78)
Biggest drop (S&P 500)
−79% (−19%)
Market sensitivity (beta)
0.75
Purchases copied
2

Trade by trade

Howell Peyton R: trades against the S&P 500 afterwards
MeasuredTrades countedAverage vs S&P 500MedianWent the right wayYearst-statisticp-valueEvidence
Purchases, 3 months after the report 2 −20.0% −20.0% 0% 2 — — Not enough years
Purchases, 6 months after the report 2 −45.8% −45.8% 0% 2 — — Not enough years
Purchases, 12 months after the report 2 −7.1% −7.1% 50% 2 — — Not enough years
Purchases, 12 months after the trade 2 −16.2% −16.2% 50% 2 — — Not enough years
Sales, 3 months after the report 17 −1.8% −4.0% 65% 7 −1.40 0.21 No reliable evidence
Sales, 12 months after the report 17 −3.9% −7.4% 77% 7 0.34 0.75 No reliable evidence
Sales, 12 months after the trade 17 −4.0% −10.2% 71% 7 0.35 0.74 No reliable evidence

“Average vs S&P 500” is the stock’s return including dividends minus the index’s over the same dates, from the close on the first trading day after the report, or from the close on the trade date. Only windows that have finished are counted. For sales, a negative figure means the stock lagged after it was sold, so selling was the right call (green). “Went the right way” is the share of purchases that beat the index, or of sales that trailed it. The t-statistic uses one average per year of reports, because one person’s trades bunch into the same stock and weeks, and needs trades in at least four different years; the p-value comes from the t distribution with that number of years (with four years, a t of 2 has p = 0.14). “Some evidence” means p under 5%, “strong evidence” p under 1% over at least six years.

Companies traded

CompanyTitle on the latest filingPurchasesSalesFirst reportLatest report
Cencora COR Executive Vice President017June 22, 2012April 5, 2018
Tandem Diabetes Care Inc TNDM —20May 10, 2022May 19, 2023

Trades and what followed

Moves are against the S&P 500; green means the trade went the insider’s way.

ReportedTradedCompanyTradeValue3 months after report12 months after report12 months after trade
May 19, 2023May 17, 2023 TNDM Purchase $90,480 −9.4%+45.0%+26.2%
May 10, 2022May 6, 2022 TNDM Purchase $149,695 −30.6%−59.3%−58.5%
April 5, 2018April 4, 2018 COR Sale $248,160 −3.1%−18.9%−20.1%
March 8, 2018March 7, 2018 COR Sale $281,340 −12.8%−21.5%−21.2%
March 2, 2018March 1, 2018 COR Sale $1,613,730 −12.2%−21.6%−18.5%
February 8, 2018February 7, 2018 COR Sale $274,800 −7.0%−9.0%−11.9%
January 9, 2018January 8, 2018 COR Sale $285,330 −6.3%−16.2%−15.8%
December 15, 2017December 14, 2017 COR Sale $1,596,660 −4.0%−10.9%−10.2%
December 7, 2017December 6, 2017 COR Sale $258,600 +11.7%−4.5%−2.2%
December 4, 2017November 30, 2017 COR Sale $808,493 +7.8%−2.6%+0.7%
November 13, 2017November 8, 2017 COR Sale $224,610 +23.6%+14.1%+10.7%
September 26, 2017September 25, 2017 COR Sale $260,186 +5.4%−5.9%−6.4%
August 17, 2017August 16, 2017 COR Sale $1,600,000 −4.9%−5.6%−6.8%
March 6, 2017March 3, 2017 COR Sale $4,131,450 +1.0%−7.4%−11.7%
August 9, 2016August 5, 2016 COR Sale $4,375,800 −20.0%−23.0%−24.2%
March 16, 2015March 13, 2015 COR Sale $4,867,866 −0.6%−19.9%−16.5%
June 23, 2014June 20, 2014 COR Sale $3,218,850 +4.0%+42.6%+46.3%
December 12, 2013December 10, 2013 COR Sale $3,191,290 −6.5%+20.1%+17.5%
June 22, 2012June 21, 2012 COR Sale $1,701,450 −6.9%+23.6%+22.1%

Open-market purchases and sales of at least $10,000 in companies we cover, from SEC Form 4 filings; sales made under a pre-set Rule 10b5-1 plan are not shown. “Not yet” means the window has not finished or the share price was under $5 at entry. These are the shares’ moves after each trade: they say nothing about why Howell Peyton R traded and do not suggest the use of non-public information. How every insider compares · the insider trading backtest.